Fair Value Downside
Overvalued Stocks – Page 28
Stocks trading above PriceToWorth Primary Fair Value, ranked by valuation confidence, sector-aware valuation risk, financial evidence and market credibility.
Showing 649–672 of 794 stocks
Page 28 of 34
Data as of
Oct 24, 2026
Criteria
At least 10% downside to PriceToWorth Primary Fair Value, Medium-or-better Primary Fair Value confidence, common equity and $100M+ market cap by default.
Ranking
Primary-Fair-Value risk model: bounded downside, Primary Fair Value confidence, sector-aware multiple stretch, growth offsets, market size, major-index credibility and applicable accounting-risk checks. Analyst data and component valuation models do not affect this ranking.
Data quality
Validated results require usable primary evidence and apply sector-appropriate quality checks; unavailable supporting metrics remain neutral rather than becoming zero.
Strong favorable
Favorable
Watch
Risk / negative
Neutral
↔ Scroll horizontally to compare all relevant metrics Swipe horizontally to compare all relevant metrics
Rank
Ticker
Market
Fair Value Gap
Analyst Upside
P/E
P/B
P/S
Dividend Yield
Health
Market Cap
#649
EJPRY
OTC
-12.1% Downside
Fair
—
17.3x
1.3x
1.3x
—
Good
$26.11B
#650
GVDNY
OTC
-11.1% Downside
Fair
0.1% Upside
38.6x
8.4x
5.0x
1.2%
Good
$44.67B
#651
UNCRY
OTC
-11.0% Downside
Fair
63.4% Upside
10.1x
1.5x
4.3x
3.0%
Good
$120.80B
#652
FMBL
OTC
-31.4% Downside
Overvalued
—
31.1x
1.0x
4.4x
1.1%
Fair
$1.19B
#653
GLTK
OTC
-26.5% Downside
Overvalued
—
—
—
7.5x
—
Fair
$249.00M
#654
ATUSF
OTC
-23.4% Downside
Overvalued
—
10.3x
2.3x
39.9x
0.8%
Great
$2.18B
#655
BTSGY
OTC
-46.8% Downside
Overvalued
—
—
0.5x
1.3x
—
Fair
$910.20M
#656
TSGMY
OTC
-45.9% Downside
Overvalued
—
10.6x
2.3x
1.4x
—
Great
$1.28B
#657
UVPOF
OTC
-35.6% Downside
Overvalued
—
10.7x
2.4x
0.8x
—
Great
$373.00M
#658
BVILY
OTC
-33.6% Downside
Overvalued
—
32.8x
4.3x
2.5x
0.9%
Good
$3.19B
#659
OSGSF
OTC
-30.7% Downside
Overvalued
—
15.7x
1.2x
1.1x
2.1%
Great
$14.04B
#660
KGTFY
OTC
-25.7% Downside
Overvalued
—
12.5x
1.3x
4.8x
5.7%
Good
$17.80B
#661
CLPHY
OTC
-24.4% Downside
Overvalued
8.8% Upside
17.7x
1.7x
2.2x
3.9%
Good
$24.50B
#662
BIOGY
OTC
-23.8% Downside
Overvalued
—
37.1x
11.7x
8.1x
2.3%
Great
$1.30B
#663
NBGIF
OTC
-21.1% Downside
Overvalued
—
12.0x
1.4x
4.9x
3.6%
Fair
$14.98B
#664
IRPSY
OTC
-20.6% Downside
Overvalued
—
5.4x
0.8x
0.2x
0.9%
Great
$1.70B
#665
CESTY
OTC
-19.1% Downside
Overvalued
—
—
0.2x
6.9x
1.3%
Weak
$238.40M
#666
RCRRF
OTC
-18.5% Downside
Overvalued
—
45.9x
15.0x
6.9x
0.1%
Great
$169.20B
#667
DPMLF
OTC
-18.4% Downside
Overvalued
—
14.1x
3.2x
7.1x
0.4%
Excellent
$9.13B
#668
FNEVY
OTC
-17.8% Downside
Fair
—
12.7x
0.7x
0.9x
3.8%
Good
$1.52B
#669
CAIXY
OTC
-16.5% Downside
Fair
32.4% Upside
13.3x
2.0x
5.0x
2.9%
Fair
$87.21B
#670
RCRUY
OTC
-15.7% Downside
Fair
—
45.9x
15.0x
6.9x
—
Great
$169.20B
#671
NPSCY
OTC
-15.5% Downside
Fair
—
11.9x
0.6x
0.3x
—
Great
$21.79B
#672
AJNMY
OTC
-14.7% Downside
Fair
—
34.8x
6.2x
3.0x
0.3%
Good
$30.82B
No company or ticker on this page matches your search.